199 related articles for article (PubMed ID: 37154567)
1. Siglec cis-ligands and their roles in the immune system.
Tsubata T
Glycobiology; 2023 Aug; 33(7):532-544. PubMed ID: 37154567
[TBL] [Abstract][Full Text] [Related]
2. Proximity labeling of cis-ligands of CD22/Siglec-2 reveals stepwise α2,6 sialic acid-dependent and -independent interactions.
Alborzian Deh Sheikh A; Akatsu C; Imamura A; Abdu-Allah HHM; Takematsu H; Ando H; Ishida H; Tsubata T
Biochem Biophys Res Commun; 2018 Jan; 495(1):854-859. PubMed ID: 29146181
[TBL] [Abstract][Full Text] [Related]
3. The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells.
Tsubata T
Int Immunol; 2023 Oct; 35(10):461-473. PubMed ID: 37504378
[TBL] [Abstract][Full Text] [Related]
4. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
Nitschke L
Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
[TBL] [Abstract][Full Text] [Related]
5. Sialic acids and autoimmune disease.
Mahajan VS; Pillai S
Immunol Rev; 2016 Jan; 269(1):145-61. PubMed ID: 26683151
[TBL] [Abstract][Full Text] [Related]
6. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
Meyer SJ; Linder AT; Brandl C; Nitschke L
Front Immunol; 2018; 9():2820. PubMed ID: 30559744
[TBL] [Abstract][Full Text] [Related]
7. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
Front Immunol; 2018; 9():820. PubMed ID: 29725338
[TBL] [Abstract][Full Text] [Related]
8. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
Nitschke L
Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
[TBL] [Abstract][Full Text] [Related]
9. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
[TBL] [Abstract][Full Text] [Related]
10. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
[TBL] [Abstract][Full Text] [Related]
11. Identification of Siglec Cis-Ligands by Proximity Labeling.
Alborzian Deh Sheikh A; Akatsu C; Tsubata T
Methods Mol Biol; 2020; 2132():75-83. PubMed ID: 32306316
[TBL] [Abstract][Full Text] [Related]
12. High-affinity ligands of Siglec receptors and their therapeutic potentials.
Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
[TBL] [Abstract][Full Text] [Related]
13. Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking.
Han S; Collins BE; Bengtson P; Paulson JC
Nat Chem Biol; 2005 Jul; 1(2):93-7. PubMed ID: 16408005
[TBL] [Abstract][Full Text] [Related]
14. Identification of Siglec Ligands Using a Proximity Labeling Method.
Chang L; Chen YJ; Fan CY; Tang CJ; Chen YH; Low PY; Ventura A; Lin CC; Chen YJ; Angata T
J Proteome Res; 2017 Oct; 16(10):3929-3941. PubMed ID: 28899088
[TBL] [Abstract][Full Text] [Related]
15. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.
Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA
J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856
[TBL] [Abstract][Full Text] [Related]
16. Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity.
Tateno H; Li H; Schur MJ; Bovin N; Crocker PR; Wakarchuk WW; Paulson JC
Mol Cell Biol; 2007 Aug; 27(16):5699-710. PubMed ID: 17562860
[TBL] [Abstract][Full Text] [Related]
17. Impact of Siglecs on autoimmune diseases.
Brzezicka KA; Paulson JC
Mol Aspects Med; 2023 Apr; 90():101140. PubMed ID: 36055802
[TBL] [Abstract][Full Text] [Related]
18. Siglec Signaling in the Tumor Microenvironment.
van Houtum EJH; Büll C; Cornelissen LAM; Adema GJ
Front Immunol; 2021; 12():790317. PubMed ID: 34966391
[TBL] [Abstract][Full Text] [Related]
19. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.
Pfrengle F; Macauley MS; Kawasaki N; Paulson JC
J Immunol; 2013 Aug; 191(4):1724-31. PubMed ID: 23836061
[TBL] [Abstract][Full Text] [Related]
20. Early murine T-lymphocyte activation is accompanied by a switch from N-Glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-E.
Redelinghuys P; Antonopoulos A; Liu Y; Campanero-Rhodes MA; McKenzie E; Haslam SM; Dell A; Feizi T; Crocker PR
J Biol Chem; 2011 Oct; 286(40):34522-32. PubMed ID: 21835922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]